Antithrombin-lowering in hemophilia: a closer look at fitusiran
Descrição
Fitusiran update following EAHAD 2021 Congress – WFH - World Federation of Hemophilia
Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
Monthly injections of fitusiran found to reduce bleeds in patients with hemophilia A and B
IJMS, Free Full-Text
Switch to Fitusiran Reduces Bleed Rates in Severe Hemophilia A and B
Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy
RNAi for the treatment of people with hemophilia
Innovations in Managing Hemophilia
Hemophilia A (Factor VIII Deficiency): Practice Essentials, Background, Pathophysiology
Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
